Research on exercise-induced asthma
Posted Sunday, 30 November, 2008
Numerous studies have highlighted the increased prevalence of exercise-induced asthma (EIA) in endurance-trained athletes. The prevention and treatment of EIA usually involves the use of inhaled b2-agonists bronchodilators. Several studies, as well as clinical observations, report that daily use of b2-agonists bronchodilators might lead to tolerance to the protective effect of these substances against EIB, and to delayed recovery from bronchoconstriction. In an effort to improve understanding of the effect of chronic use of inhaled b2-agonists bronchodilators in EIA in the athletic population, researchers at the University of Sydney and Royal prince Alfred Hospital (Sydney) are conducted a study to determine the effects of different types of inhaled b2-agonists on bronchial reactivity.
If you are older than 18 yrs, training a minimum of 3 times a week, and taking asthma medications, you have the opportunity to be part of this research study. As a participant, you will have access to some fundamental data regarding your asthma, including full lung function assessment as well as results to a bronchial challenge test. This information may assist in improving the control of your asthma.
All testing will be conducted at Royal Prince Alfred Hospital, Department of Respiratory Medicine. Subjects will be given some financial support at the successful completion of the study.
If you would like further information or to be included in the study, please contact the Clare Perry (clarep@med.usyd.edu.au or (02) 9515 6121).
Facebook 
Twitter
i